Levocarnitine and its derivatives are generally well tolerated in adults with occasional gastrointestinal upset and restlessness
adults rising from 1,884 in the second quarter of 2021 to 8,819 in the first quarter of 2026
Wells PG, Lee CJ, McCallum GP, Perstin J, Harper PA
Diaconu CC, Cozma MA, Dobric EC, Gheorghe G, Jichitu A, Ionescu VA, Nicolae AC, Drgoi CM, Gman MA
You would never know it happened by looking at the vial
FDA sent a warning letter to HealthPartners Neuroscience Center Research and Innovation in Saint Paul, MN for objectionable conditions following a nonclinical laboratory inspection conducted as part of FDAs Bioresearch Monitoring Program